Have you ever been concerned about your eating? We're inviting adults in the U.S. who have ever had anorexia nervosa, atypical anorexia nervosa, bulimia nervosa, binge-eating disorder, or avoidant/restrictive food intake disorder (ARFID) at any point in their life to take our survey. No official medical diagnosis is required. Common signs of different eating disorders may include: restricting the amount or type of food you eat or eating excessive amounts of food in one sitting. Some other possible signs are making yourself throw up, using diet pills or laxatives, excessively exercising, or fasting to alter your weight. Only with your help can we the causes and potential cures for these disorders. Eligible participants who complete Core Questionnaires and return their saliva sample will receive a $30 gift card.

Have you been diagnosed with pancreatic adenocarcinoma? If so, you may be a good fit to help us learn if combination treatment with specific drugs may stimulate the body's immune system against cancer cells.

Do you want to experience a nurturing, empowering and wellness-centered prenatal care that helps you reduce the chance of getting diabetes in pregnancy? Then the Targeted Lifestyle Change (TLC) Study might be for you! TLC is specially designed to help you learn how to eat, move, and live for two during pregnancy to explore whether we can reduce the risks of diabetes in pregnancy. Compensation provided.

Do you have bladder cancer and have had your bladder removed? If so, you may be able to take part in a research study to determine if patients need additional treatment called immunotherapy to prevent cancer from coming back.

Have you been diagnosed with Multiple Myeloma? Have you received idecabtagene vicleucel (ide-cel (Abecma)) CAR-T treatment? If so, you may be able to take part in a research study looking at for how long a new drug called iberdomide will keep Multiple Myeloma under control (in remission).

Have you been diagnosed with large B-cell lymphoma (LBCL) and have not yet received treament? If so, you may be able to take part in a research study looking at the efficacy of giving a drug called glofitamab in combination with other drugs. The drugs are: polatuzumab vedotin (Pola) (also known as Polivy→) and rituximab (R) (also known as Rituxan→ and MabThera→), as well as a group of chemotherapy drugs, cyclophosphamide (C), doxorubicin (H), and prednisone (P) (referred to as Pola-R-CHP).

Do you want to know more about your calf muscles? Do you get tired easily? You may be able to participate in a research study to find out the effect of your calf muscle length on your muscle activity and fatigue.

What factors influence how the brain takes in sugar to use it as energy? If you are between the ages of 18-45 years old and are healthy and of normal weight, you might be eligible to participate in this study to help us understand how the way sugar enters the body affects how sugar enters the brain.

Do you identify as LGBTQ+ or queer, and have you gone through all or part of a family planning process? Or, do you aid LGBTQ+ individuals in their family planning as part of your work? If so, we are seeking perspectives on these processes and the types of stress and social support experienced during them.

Efgartigimod has been approved by the U.S. FDA (Food and Drug Administration) as a treatment for adult patients with gMG in whom AChR-Ab's are present. However, it was not approved it for the form of gMG that is AChR Ab seronegative (antibodies not present). and therefore this study is now testing how efragtigimod works in patients without any antibodies,